Latest news
Neurizon advances ALS trial in Q4 FY26 - The AustralianThe Australian · Tue, 04 Aug 2026 03:12:00 GMTNeurizon to Outline ALS Trial Progress and NUZ-001 Strategy at Melbourne Investor Briefing - TipRanksTipRanks · Wed, 29 Jul 2026 04:15:29 GMTNeurizon Therapeutics Completes Regimen I Enrolment in HEALEY ALS Platform Trial Ahead of Melbourne Investor Briefing - kalkine.com.aukalkine.com.au · Wed, 29 Jul 2026 04:02:01 GMT